Research
Hormonal
Physical activity may counteract the aging-related decline in bone mass but does not strongly attenuate menopause-related bone loss in women.
Consider pharmacologic therapy for postmenopausal women to prevent bone loss, even if active.
StrongQualifiesmedium confidence
There is currently no strong evidence that even vigorous physical activity attenuates the menopause-related loss of bone mineral in women.
Why this rating
Supported by observational studies, though lacking large RCTs.
Source
Physical Activity and Bone Health
Wendy M. Kohrt et al. · Medicine & Science in Sports & Exercise · 2004
DOI 10.1249/01.mss.0000142662.21767.58
reviewCited 1,017×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →